Response to 4 cycles of BEACOPP
| Response . | Institution, N (%) . | Central review, N (%) . |
|---|---|---|
| Complete response (CR) | 12 (12) | 3 (5) |
| Partial response 1 (PR1) | 60 (62) | 52 (81) |
| Partial response 2 (PR2) | 24 (25)* | 9 (14) |
| Stable disease (SD) | 1 (1) | 0 (0) |
| Progressive disease (PD) | 0 (0) | 0 (0) |
| Not evaluable/unknown | 1 | 34 |
| Response . | Institution, N (%) . | Central review, N (%) . |
|---|---|---|
| Complete response (CR) | 12 (12) | 3 (5) |
| Partial response 1 (PR1) | 60 (62) | 52 (81) |
| Partial response 2 (PR2) | 24 (25)* | 9 (14) |
| Stable disease (SD) | 1 (1) | 0 (0) |
| Progressive disease (PD) | 0 (0) | 0 (0) |
| Not evaluable/unknown | 1 | 34 |
Two patients included here only completed cycles 1 and 2 of BEACOPP.